Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma

키워드

참고문헌 (34)

1. 김영준, "The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO", Brain Tumor Research and Treatment, 10(2), pp.83~93 (2022), 대한뇌종양학회
2. Mohile NA, "Therapy for diffuse astrocytic and oligodendroglial tumors in adults : ASCO-SNO guideline", J Clin Oncol, 40, pp.403~426 (2022)
3. Weller M, "EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood", Nat Rev Clin Oncol, 18, pp.170~186 (2021)
4. Mallick S, "Hypofractionated accelerated radiotherapy(HART)with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma : a phase II randomized trial(HART-GBM trial)", J Neurooncol, 140, pp.75~82 (2018)
5. Cho KH, "Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas", Int J Radiat Oncol Biol Phys, 78, pp.390~397 (2010)
6. Zhong L, "Efficacy of moderately hypofractionated simultaneous integrated boost intensitymodulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme : a single-institution experience", Radiat Oncol, 14, pp.104~ (2019)
7. Singh R, "Dose escalated radiation therapy for glioblastoma multiforme : an international systematic review and meta-analysis of 22 prospective trials", Int J Radiat Oncol Biol Phys, 111, pp.371~384 (2021)
8. Gondi V, "Radiotherapy(RT)dose-intensification(DI)using intensitymodulated RT(IMRT)versus standard-dose(SD)RT with temozolomide(TMZ)in newly diagnosed glioblastoma(GBM) : preliminary results of NRG Oncology BN001", Int J Radiat Oncol Biol Phys, 108, pp.S22~S23 (2020)
9. Ferro M, "Post-operative accelerated-hypofractionated chemoradiation with volumetric modulated arc therapy and simultaneous integrated boost in glioblastoma : a phase I study(ISIDE-BT-2)", Front Oncol, 10, pp.626400~ (2020)
10. Kim N, "Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma", Strahlenther Onkol, 196, pp.58~69 (2020)
11. Wee CW, "Novel recursive partitioning analysis classification for newly diagnosed glioblastoma : a multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status", Radiother Oncol, 123, pp.106~111 (2017)
12. Bell EH, "Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era : a correlative analysis based on NRG oncology RTOG 0525", JAMA Oncol, 3, pp.784~792 (2017)
13. Kim WJ, "Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma", J Neurooncol, 143, pp.321~328 (2019)
14. Mendez JS, "Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma", J Neurooncol, 127, pp.329~335 (2016)
15. Grossman SA, "Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide", Clin Cancer Res, 17, pp.5473~5480 (2011)
16. Byun HK, "Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma : clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era", Radiat Oncol, 14, pp.51~ (2019)
17. Rudra S, "Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma", Int J Radiat Oncol Biol Phys, 101, pp.217~225 (2018)
18. Grossman SA, "Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors", J Natl Compr Canc Netw, 13, pp.1225~1231 (2015)
19. Wang X, "Low lymphocyte count is associated with radiotherapy parameters and affects the outcomes of esophageal squamous cell carcinoma patients", Front Oncol, 10, pp.997~ (2020)
20. Kim N, "Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer : a comparative analysis of proton versus photon therapy", Radiother Oncol, 156, pp.166~173 (2021)
21. Wild AT, "Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer", Int J Radiat Oncol Biol Phys, 94, pp.571~579 (2016)
22. Kim N, "Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab", Cancer Immunol Immunother, 70, pp.1593~1603 (2021)
23. Shin J, "HEDOS-a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on wholebody blood flow simulations", Phys Med Biol, 66, pp.164001~ (2021)
24. Yovino S, "The etiology of treatment-related lymphopenia in patients with malignant gliomas : modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells", Cancer Invest, 31, pp.140~144 (2013)
25. Huang J, "Clinical and dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent temozolomide for high-grade glioma", Int J Radiat Oncol Biol Phys, 92, pp.1000~1007 (2015)
26. Mohan R, "Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients : phase II randomized study of protons vs photons", Neuro Oncol, 23, pp.284~294 (2021)
27. Stupp R, "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma", N Engl J Med, 352, pp.987~996 (2005)
28. Hothorn T, "On the exact distribution of maximally selected rank statistics", Comput Stat Data Anal, 43, pp.121~137 (2003)
29. Wee CW, "Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort : is short-course radiotherapy enough or is it a matter of selection?", J Neurooncol, 148, pp.57~65 (2020)
30. Mak KS, "Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme : an analysis of the national cancer database", Cancer Med, 6, pp.1192~1200 (2017)
31. Gzell C, "Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide", J Neurooncol, 119, pp.187~196 (2014)
32. Amen DG, "Gender-based cerebral perfusion differences in 46, 034functional neuroimaging scans", J Alzheimers Dis, 60, pp.605~614 (2017)
33. Lim M, "Current state of immunotherapy for glioblastoma", Nat Rev Clin Oncol, 15, pp.422~442 (2018)
34. Lambin P, "Lymphocyte-sparing radiotherapy : the rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy", Semin Radiat Oncol, 30, pp.187~193 (2020)

관련 논문AI추천